Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer-Subset analysis of the ESPAC-1 data.

Carter R, Stocken DD, Ghaneh P, Bramhall SR, Olah A, Kelemen D, Bassi C, Friess H, Dervenis C, Spry N, Büchler MW, Neoptolemos JP; European Study Group for Pancreatic Cancer (ESPAC)..

Int J Cancer. 2009 Jun 15;124(12):2960-5. doi: 10.1002/ijc.24270.

2.

Neoadjuvant and adjuvant strategies for pancreatic cancer.

Ghaneh P, Smith R, Tudor-Smith C, Raraty M, Neoptolemos JP.

Eur J Surg Oncol. 2008 Mar;34(3):297-305. Epub 2007 Oct 22. Review.

PMID:
17936564
3.

Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.

Link KH, Leder G, Formentini A, Fortnagel G, Kornmann M, Schatz M, Beger HG.

Gan To Kagaku Ryoho. 1999 Jan;26(1):10-40. Review.

PMID:
9987495
4.
5.

Adjuvant therapy in pancreatic cancer: historical and current perspectives.

Neoptolemos JP, Cunningham D, Friess H, Bassi C, Stocken DD, Tait DM, Dunn JA, Dervenis C, Lacaine F, Hickey H, Raraty MG, Ghaneh P, Büchler MW.

Ann Oncol. 2003 May;14(5):675-92. Review.

PMID:
12702520
6.

Resection and radiochemotherapy of pancreatic cancer--the future?

Link KH, Formentini A, Leder G, Fortnagel G, Sartori N, Schatz M, Beger HG.

Langenbecks Arch Surg. 1998 Apr;383(2):134-44. Review.

PMID:
9641886
7.

Adjuvant therapy for pancreatic cancer.

Ghaneh P, Slavin J, Sutton R, Neoptolemos JP.

Swiss Surg. 2000;6(5):289-95. Review.

PMID:
11077498
9.

Adjuvant therapy in pancreatic cancer: a critical appraisal.

Oettle H, Neuhaus P.

Drugs. 2007;67(16):2293-310. Review.

PMID:
17983252
10.

The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX.

Fogelman DR, Chen J, Chabot JA, Allendorf JD, Schrope BA, Ennis RD, Schreibman SM, Fine RL.

Surg Oncol Clin N Am. 2004 Oct;13(4):711-35, x. Review.

PMID:
15350944
11.

The case for routine use of adjuvant therapy in pancreatic cancer.

Kennedy EP, Yeo CJ.

J Surg Oncol. 2007 Jun 1;95(7):597-603. Review.

PMID:
17230543
12.

A systematic overview of chemotherapy effects in colorectal cancer.

Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care..

Acta Oncol. 2001;40(2-3):282-308. Review.

PMID:
11441937
13.

[Adjuvant treatment of pancreatic cancer].

Oettle H.

Zentralbl Chir. 2003 May;128(5):411-8. Review. German.

PMID:
12813641
14.

Adjuvant therapy in pancreatic cancer.

Ghaneh P, Slavin J, Sutton R, Hartley M, Neoptolemos JP.

World J Gastroenterol. 2001 Aug;7(4):482-9. Review.

15.

Adjuvant therapy in pancreatic cancer.

Jones OP, Melling JD, Ghaneh P.

World J Gastroenterol. 2014 Oct 28;20(40):14733-46. doi: 10.3748/wjg.v20.i40.14733. Review.

16.

ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer.

Neoptolemos JP, Kerr DJ, Beger H, Link K, Pederzoli P, Bassi C, Dervenis C, Fernandez-Cruz L, Laçaine F, Friess H, Büchler M.

Digestion. 1997;58(6):570-7. Review.

PMID:
9438604
17.

A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs.

Carrato A, Falcone A, Ducreux M, Valle JW, Parnaby A, Djazouli K, Alnwick-Allu K, Hutchings A, Palaska C, Parthenaki I.

J Gastrointest Cancer. 2015 Sep;46(3):201-11. doi: 10.1007/s12029-015-9724-1. Review.

18.

Simultaneous analysis of quality of life and survival data.

Billingham LJ, Abrams KR.

Stat Methods Med Res. 2002 Feb;11(1):25-48. Review.

PMID:
11923992

Supplemental Content

Support Center